{"product_id":"adcetris-50mg-infusion-vial","title":"Adcetris 50mg infusion vial","description":"\u003ch2\u003eAdcetris 50mg powder for intravenous infusion\u003c\/h2\u003e\u003cp\u003eAdcetris by Takeda contains brentuximab vedotin, an antibody-drug conjugate that combines a CD30-targeting monoclonal antibody with a cell-killing medicine. Targeted treatment can still affect healthy tissues and cause serious side effects.\u003c\/p\u003e\u003ch3\u003eWhat is Adcetris used for?\u003c\/h3\u003e\u003cp\u003eAdcetris is used in selected lymphoma treatment regimens, including certain cases of Hodgkin lymphoma, systemic anaplastic large cell lymphoma and CD30-positive cutaneous T-cell lymphoma. Eligibility depends on the specific diagnosis, disease markers, prior treatment and locally approved product information.\u003c\/p\u003e\u003ch3\u003eProduct details\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eBrand: Adcetris.\u003c\/li\u003e\n\u003cli\u003eManufacturer: Takeda.\u003c\/li\u003e\n\u003cli\u003eActive ingredient: brentuximab vedotin.\u003c\/li\u003e\n\u003cli\u003eStrength: 50 mg per vial.\u003c\/li\u003e\n\u003cli\u003eForm: powder for preparation of an intravenous infusion.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePreparation and treatment schedule\u003c\/h3\u003e\u003cp\u003eReconstitution, dilution, dose selection, infusion timing and treatment cycles are managed by the oncology team using the manufacturer's instructions and the prescribed regimen. Treatment schedules vary; there is no single schedule or cycle count suitable for every patient.\u003c\/p\u003e\u003ch3\u003eImportant precautions\u003c\/h3\u003e\u003cp\u003eImportant risks include peripheral neuropathy, low blood cell counts, serious infections and rare serious neurological complications such as progressive multifocal leukoencephalopathy (PML). Combination with bleomycin presents a serious lung-toxicity risk and must be checked against the approved product information. Pregnancy, breastfeeding and contraception require specialist advice.\u003c\/p\u003e\u003ch3\u003ePossible side effects\u003c\/h3\u003e\u003cp\u003ePossible side effects include tingling or numbness in the hands or feet, fatigue, nausea, diarrhoea, constipation and reduced white blood cell counts. New neurological symptoms or signs of infection require prompt medical attention. Refer to the product leaflet for full safety information.\u003c\/p\u003e\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWhat does Adcetris target?\u003c\/strong\u003e\u003cbr\u003eBrentuximab vedotin targets CD30, a protein found on certain lymphoma cells.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow many treatment cycles are needed?\u003c\/strong\u003e\u003cbr\u003eThe oncology team determines the number of cycles according to the treatment regimen, response and side effects. A product listing cannot predict cure or treatment duration.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eHow should the vial be stored?\u003c\/strong\u003e\u003cbr\u003eFollow the exact storage instructions on the supplied pack and manufacturer's leaflet. Prepared infusions have separate handling and storage requirements.\u003c\/p\u003e","brand":"Takeda","offers":[{"title":"Default Title","offer_id":50948865458341,"sku":"101677","price":69296.0,"currency_code":"EGP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0657\/8166\/1861\/files\/Adcetris_50mg_infusion_vial.jpg?v=1793123320","url":"https:\/\/maipharmacy.co\/ar\/products\/adcetris-50mg-infusion-vial","provider":"Mai Pharmacy","version":"1.0","type":"link"}